Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction.

What is the role of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with chronic heart failure with reduced ejection fraction? An SGLT2i reduces mortality, heart failure hospitalizations, and improves quality of life when added to other medications for heart failure with reduced